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‘‘The beginning of wisdom is found in doubting; by doubting we come to question, and by seeking we may
come upon the truth.’’ – Pierre Abelard
CD8 is a glycoprotein expressed on hematopoietic cells. Two isoforms of CD8, CD8ab and CD8aa, have been
identified that are distinct in their expression and function. Whereas CD8ab serves as a T cell receptor (TCR)
coreceptor to enhance the functional avidity and is constitutively expressed on MHC class I-restricted T cells,
CD8aa marks T cells that are distinct from the conventional thymus-selected and MHC-restricted CD4+ or
CD8ab+ T cells. Inconsistent with a coreceptor function, CD8aa decreases antigen sensitivity of the TCR,
and it can be transiently or permanently expressed on T cells, regardless of the MHC restriction of the
TCR or the presence of conventional coreceptors. Together, these observations indicate that CD8aa on
T cells marks a differentiation stage and that it likely functions as a TCR corepressor to negatively regulate
T cell activation.Introduction
The CD8 isoform, CD8aa, when expressed on T cells, is fre-
quently described as an inefficient T cell receptor (TCR) corecep-
tor. In analogy to the conventional TCR coreceptors, CD4 and
CD8ab, that mark thymus-selected MHC class II- or class I-re-
stricted TCRab+ T cells, respectively, CD8aa also binds MHC li-
gands and is used as a lineage determinant to identify T cells that
divert from the mainstream T cell subsets in terms of their origin,
ontogeny, specificity, and function (Cheroutre, 2004). In mouse,
CD8aa single-positive (SP) T cells predominate among the intra-
epithelial lymphocytes (IEL) of the small intestine and typically
display an activated phenotype together with a characteristic
innate-like signature (Cheroutre, 2004). In addition, CD8aa and
CD8ab are flexibly regulated on thymocytes depending on the
developmental stage (Ellmeier et al., 1998; Garefalaki et al.,
2002; Feik et al., 2005), and CD8aa can also be expressed to-
gether with CD4 (Paliard et al., 1988; Reimann and Rudolphi,
1995; Kenny et al., 2004) or CD8ab (Terry et al., 1990; Moebius
et al., 1991; Konno et al., 2002; Madakamutil et al., 2004) on ac-
tivatedmature TCRab+ T cells. The latter implies that CD8aamay
not serve as a conventional MHC class I-binding TCR coreceptor
on these cells.
The activated status of CD8aa-expressing mature T cells
suggests a relationship between CD8aa and the TCR-CD3
complex. The expression of CD8aa on TCRgd+ as well as on
TCRab+ cells or together with CD4 or CD8ab on MHC class
II- or MHC class I-restricted T cells indicates that this relation-
ship is not limited by the nature of the TCR or coreceptor and
that it is independent of MHC restriction. These observations
also imply that the link between CD8aa and the TCR-CD3 ac-
tivation complex is not directed by the adaptive TCR subunit
but rather that they point toward a functional connection with
the invariant signaling modules of the CD3 complex. The ability
of the CD8a cytoplasmic tail to associate with both the early
Src kinase p56lck (Veillette et al., 1988), which serves to phos-
phorylate immunoreceptor tyrosine-based activation motifs
(ITAMs) of the CD3 components, and the linker of activationof T cells (LAT) (Bosselut et al., 1999), which mediates further
downstream signaling, connects CD8aa to proximal and distal
TCR-CD3 activation signaling cascades. Despite this link and
the capacity of CD8aa to interact with MHC class I ligands,
CD8aa neither supports positive selection of MHC class I-
restricted thymocytes (Crooks and Littman, 1994; Fung-Leung
et al., 1994; Nakayama et al., 1994) nor does it efficiently pro-
mote the productive activation of CD8-dependent MHC class I-
restricted TCRs (Renard et al., 1996; McNicol et al., 2007). Fur-
thermore, when expressed together with CD8ab, CD8aa may
downmodulate as opposed to enhance the functional avidity
of the CD8ab-TCR:Ag-MHC activation complex (Cawthon
et al., 2001; Cawthon and Alexander-Miller, 2002), meaning
that the contribution of CD8aa to the TCR-CD3 activation com-
plex can be suppressive. The differential, independent, and
highly regulated expression of CD8aa together with its unique
biological properties indicate that CD8aa is not a functional
homolog of CD8ab and suggest instead that CD8aa may serve
as an effective TCR corepressor rather than a functional TCR
coreceptor.
This reviewwill focus on the various aspects of CD8aa expres-
sion and function on T cells, encompassing the complex tran-
scriptional organization of the Cd8 locus, the inhibitory effects
of CD8aa on TCR-CD3 activation, and the consequences of
CD8aa expression on the fate of developing thymocytes and
activated mature T cells.
Transcriptional Regulation of the Cd8 Locus
In contrast to the CD8ab expression, generated by the constitu-
tive transcription of Cd8a together with Cd8b, transcription of
Cd8a can also be upregulated alone, resulting in the expression
of CD8aa homodimers (Ellmeier et al., 1998). On CD8ab+ T cells,
the induced transcription of Cd8a results in the coexpression of
CD8aa with CD8ab (Madakamutil et al., 2004). The differential
expression of CD8aa and CD8ab dimers indicates that the tran-
scription of the individual Cd8 genes is coordinately as well as
independently regulated.Immunity 28, February 2008 ª2008 Elsevier Inc. 149
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36 Kb in mice and 56 Kb in human (Kieffer et al., 2002). Numer-
ous regulatory transcription elements have been identified dis-
tributed along this locus and in particular within the noncoding
gene interval upstream of the Cd8a gene. Besides binding sites
for several transcription factors, including Runx1 and 3, Ikaros,
and GATA-3, various CD8 enhancer (E8) sites were identified
that display different capacities to regulateCd8 transcription (Ki-
oussis and Ellmeier, 2002). Enhancer-driven reporter gene tran-
scription or individual and combined deletions indicated that
specific enhancers (E8I–V) control CD8 expression in various
cell types and during development or under different conditions
of activation (Ellmeier et al., 1998, 2002; Madakamutil et al.,
2004; Feik et al., 2005). Enhancer E8I, for example, is not re-
quired for CD8ab or CD8aa expression in developing thymo-
cytes, whereas constitutive expression of CD8aa on IEL or tran-
sient TCR-CD3 activation-induced expression of CD8aa on
mature CD8ab+ T cells was abolished in the absence of a func-
tional E8I enhancer (Ellmeier et al., 1997; Madakamutil et al.,
2004). In contrast, E8II and E8III are required for expression of
CD8ab and CD8aa on immature thymocytes whereas E8IV drives
expression of CD8ab on single-positive (SP) thymocytes and
mature T cells including a subset of CD4+ T cells (Ellmeier
et al., 1998, 2002; Feik et al., 2005). Several of the transcription
factors such as Runx, Ikaros, and GATA-3 show strong binding
preferences for particular enhancer sites or function in cohort
with various chromatin-remodeling molecules that provide pos-
itive as well as negative regulation of theCd8 locus (Kioussis and
Ellmeier, 2002). Further, the zinc finger protein MAZR (bound to
nuclear receptor corepressor complexes) controls Cd8 tran-
scription in immature thymocytes by specifically targeting the
E8II enhancer region, thus linking the enhancer function also
with negative control of transcription (Bilic et al., 2006). Another
nonredundant repressor mechanism involved in the plasticity of
CD8 expression is the epigenetic control by DNA methylation.
Initial demethylation of both Cd8a and Cd8b genes occurs dur-
ing thymocyte maturation. The retention of this demethylated
state in CD4+ T cells provided the initial evidence that these lym-
phocytes had matured from CD8ab-expressing precursor cells
(Carbone et al., 1988a). The fully methylated state of Cd8b in im-
mature DN thymocytes and TCRgd+ IEL indicates that these
cells or their precursors never transcribed Cd8b. CD8aa+
TCRab+ T-IEL, in contrast, display a unique pattern of Cd8b
methylation that differs from T cells that never expressed
CD8ab, including the CD8aa+TCRgd IEL (Hamerman et al.,
1997). Because DNA methylation is a stable but not irreversible
epigenetic signal that silences gene expression, it is possible
that the unique Cd8b methylation resulted from remethylation
of the Cd8b gene to terminate expression of CD8ab on these
CD8aa+TCRab+ T-IEL. Remethylation of the Cd8a gene has
been detected in CD4+ T cells and mature DN TCRab+ thymo-
cytes, indicating that remethylation of the Cd8 genes might be
another mechanism for epigenetic silencing of CD8 (Carbone
et al., 1988a, 1988b; Wu et al., 1990). SP CD8aa+TCRab+ IEL
in this case cannot control expression of CD8 at the level of re-
methylation of Cd8a and it is thus possible that the unique meth-
ylation pattern of Cd8b in CD8aa+TCRab+ T-IEL reflects epige-
netic regulation to silence CD8ab while permitting CD8aa
expression.150 Immunity 28, February 2008 ª2008 Elsevier Inc.CD8aa and CD8ab Protein Expression
In addition to the complex transcriptional regulation of the CD8
locus, differential expression of CD8aa and CD8ab is also regu-
lated at the protein level.WhereasCD8aprotein can be expressed
as disulphate-linked CD8aa homodimers or CD8ab hetero-
dimers, CD8b protein requires association with CD8a for its sta-
ble expression at the cell surface. This is not due to the inability
of CD8b molecules to form homodimers, which can be formed
intracellularly but are unstable and degrade rapidly. Cell-surface
expression of human CD8bb homodimers has been described
upon transfection or on lymphocytes of human CD8b transgenic
mice; however, the physiological significance of this is not known
(Devine et al., 2000). CD8a and CD8b are both membrane-
anchored glycoproteins belonging to the immunoglobulin-like
super family. Despite their insignificant sequence homology,
crystal structure analysis of their ectodomains indicated remark-
able structural similarities in shape, size, and in the surface elec-
trostatic potential of complementary determining regions (CDR)
between the paired immunoglobulin variable region-like do-
mains of CD8aa and CD8ab (Devine and Kavathas, 1999; Chang
et al., 2005). Surface plasmon resonance (SPR) analyses further
indicated that the stalk regions of the CD8a and CD8b are both
capable of presenting the Ig-like domain to interact with MHC
class I ligands (Chang et al., 2005). BIAcore binding data indi-
cated that at least for soluble CD8aa and CD8ab, the interaction
with classical MHC class I molecules occurs with comparable
affinity (Kern et al., 1999; Gao and Jakobsen, 2000; Leishman
et al., 2001). When expressed as cell-surface molecules, how-
ever, the coordinated binding of CD8ab with TCR-engaged
MHC class I is much stronger as compared to membrane-bound
CD8aa (Witte et al., 1999; Bosselut et al., 2000). These observa-
tions suggest that the ectodomain and/or the transmembrane
and cytoplasmic region of CD8b specifically contribute to en-
hance the quality of the CD8-MHC interaction. In sharp contrast,
soluble or membrane-bound CD8aa interacts with much en-
hanced affinity with the mouse thymic leukemia antigen (TL),
a nonclassical MHC class I molecule expressed in the thymus
and on small intestine epithelium (Leishman et al., 2001). The dif-
ferential affinity of CD8aa for TL and classical MHC class I mol-
ecules was largely mediated by changes in three contact resi-
dues in the exposed loops of the conserved a3 domain of TL
(Attinger et al., 2005). Analysis of CD8aa-TL cocrystals further in-
dicated that the enhanced ability of TL to interact preferentially
with CD8aa concurred with the structural elimination of its anti-
gen-presenting potential and that the cleft between the two
helical domains, a1 and a2, which defines the antigen-binding
groove for MHC class I molecules, is not existing in TL (Liu
et al., 2003). This structural feature has important functional con-
sequences and implies that TL is not an antigen-presenting mol-
ecule for TCRs and that when interacting with TL, CD8aa is not
functioning as a TCR coreceptor.
Several mutational studies indicated that the individual alpha
subunits of CD8aa homodimers contribute differentially to
establish the CD8aa-MHC class I interaction. Structural analysis
of human CD8aa-HLA-A2 (Gao et al., 1997) and mouse CD8aa-
H2-Kb (Kern et al., 1998) cocrystals confirmed this remarkable
asymmetrical interaction where one CD8a chain (CD8a1) pro-
vides approximately 75% of the contact interface, contacting
the b2-microglobulin (b2 m) and the a2 but mostly the conserved
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unit contributes some contact points with the a3 domain only.
The topology of the CD8b component of the heterodimer when
binding to MHC class I is not known, but in analogy with the
asymmetric interaction of the CD8aa subunits, two models
have been proposed. Initial studies with electrostatics and spe-
cific point mutations suggested that in the human CD8ab-MHC
class I complex, CD8b might substitute the CD8a2 subunit that
contributes the least to the CD8-MHC interaction (Gao et al.,
1997; Devine and Kavathas, 1999). In contrast, site-directed mu-
tagenesis of transfected mouse CD8 molecules showed that
mutations in CD8a1 or both subunits rendered the asymmetric
CD8aa merely nonfunctional as measured by IL-2 production,
whereas the coreceptor function of mutated CD8a paired with
wild-type CD8b was as efficient as wild-type CD8ab (Chang
et al., 2005). These data suggest that unlike human CD8ab, in
mouse, the CD8b subunit assumes the position of the CD8a1
of the CD8aa homodimers. In other studies, however, it was
shown that mouse CD8a mutants expressed as a heterodimer
with wild-type CD8bwere less capable at restoringMHC binding
compared towild-type CD8a, whereasmouse CD8b variants un-
able to substitute for CD8a1 could efficiently replace CD8a2 in
the CD8ab-MHC class I complex (Chang et al., 2006; Devine
et al., 2006). Furthermore, CD8a antibodies were able to block
the CD8a1 site but not the CD8a2 position (Chang et al., 2006),
suggesting that at least in mouse, CD8b can assume the proxi-
mal or distal position of the CD8 dimer when interacting with
MHC class I complexes.
In addition to the coordinated interaction with the antigen-pre-
senting MHC class I molecules, CD8 coreceptor also enhances
intracellular TCR activation signaling events (Figure 1; Irie
et al., 1998; Bosselut et al., 2000). CD8a physically associates
with the Src kinase p56lck via conserved binding motifs in its cy-
toplasmic domain (Veillette et al., 1988), and when coengaged
with a TCR-CD3:Ag-MHC activation complex, CD8a-associated
p56lck phosphorylates CD3z-ITAMs, which in turn recruit and
phospholylate ZAP-70 and other src homology domain 2
(SH2)-containing molecules. The binding of CD8a-associated
p56lck to CD3z-associated ZAP-70 couples the TCR coreceptor
function directly to TCR-CD3 activation. The CD8a subunit also
associates with LAT (Bosselut et al., 1999, 2000). LAT on phos-
phorylation by ZAP-70 recruits a variety of adaptor and signaling
molecules for further downstream signaling, hence linking the
contribution of the TCR coreceptor also to distal signaling cas-
cades (Zhang et al., 1998). Because only the CD8a subunit of
the CD8ab heterodimer associates with p56lck and LAT, it is
likely that the differential topology of CD8b will affect the posi-
tioning of these signaling molecules in relation to the CD3-TCR
complex. The physiological consequences of this flexibility of
CD8ab coreceptor interactions are not known but they might
represent quanitative and/or qualitative differences for TCR
activation.
CD8ab Functions as an Effective TCR Coreceptor
The ability of CD8ab to function as a superior TCR coreceptor as
compared to CD8aa is in sharp contrast to the observations that
soluble CD8aa and CD8ab show similar MHC-binding affinity
(Kern et al., 1999) and that the cytoplasmic tail of the CD8a but
not the CD8b chain provides the physical association with theTCR-CD3 signaling components p56lck and LAT (Figure 1; Veil-
lette et al., 1988; Bosselut et al., 1999). Nevertheless, the inca-
pacity of CD8aa to efficiently substitute the CD8ab coreceptor
during thymic selection of CD8b-deficient MHC class I-restricted
thymocytes (Crooks and Littman, 1994; Fung-Leung et al., 1994;
Nakayama et al., 1994) or during activation of CD8-dependent
primary T cells (McNicol et al., 2007) and the effect of CD8b
that broadens the range of antigen recognition of T cells under-
score the importance and absolute requirement of the CD8b
contribution for efficient CD8 TCR coreceptor function (Karaki
et al., 1992; Wheeler et al., 1992; Zamoyska, 1994; Renard
et al., 1996; McNicol et al., 2007). The molecular mechanisms
that render CD8b as the key subunit for CD8 TCR coreceptor
function are still somewhat mysterious. Several CD8b chimeric
constructs, specifically lacking the CD8b extracellular module
or the intracellular domain or both, showed that the ectodomain
of CD8b critically enhances the interaction of membrane-bound
CD8 with MHC class I (Witte et al., 1999; Bosselut et al., 2000),
whereas the cytoplasmic tail of CD8b augmented the associa-
tion of CD8a with the intracellular signaling molecules p56lck
and LAT (Bosselut et al., 2000). In addition, it was demonstrated
that these two physically associated domains of CD8b could en-
hance CD8 coreceptor function independently of each other
(Bosselut et al., 2000). It is not fully understood how the CD8b ec-
todomain can promoteMHC class I ligation, but one possibility is
that the shorter stalk of CD8bmight play an important role (Wong
et al., 2003). The stalk is heavily glycosylated and O-linked car-
bohydrates on the b but not the a stalk are heterogeneous, re-
sulting from complex and flexible sialylations that differ during
thymic development and upon TCR stimulation (Daniels et al.,
2001; Moody et al., 2001, 2003; Merry et al., 2003; Wong et al.,
2003). It has been postulated that the b stalk glycosylation mod-
ifications and glycan adducts might induce conformational
changes that promote the CD8-MHC class I interaction (Moody
et al., 2001). The intracellular domain of CD8b independently
promotes CD8 coreceptor function by actively recruiting the
TCR to lipid rafts and by enhancing the association of the
CD8a subunit with lipid raft-localized p56lck and LAT (Figure 1;
Arcaro et al., 2000, 2001; Pang et al., 2007). CD8ab, but not
CD8aa, physically interacts with TCR-CD3 via the CD3d and
hence substantially enhances raft association of TCR-CD3 (Dou-
cey et al., 2003). The lipid raft association of CD8ab is completely
controlled by the presence of CD8b, and for mouse, this was
shown to depend on CD8b palmitoylation (Arcaro et al., 2000),
whereas human CD8ab requires the CD8b ectodomain to pair
with CD8a to evoke lipid raft localization and effective corecep-
tor function (Pang et al., 2007).
CD8aa Corepressor Function
Historically, CD8aa has been used as a convenient molecule to
study the function of CD8. With CD8a transfectants, it was
shown that CD8aa could function as an adhesion molecule
able to strengthen the overall avidity by interacting with MHC
class I ligands that were not engaged by the TCR (Miceli et al.,
1991). The observation that tail-less CD8aa could augment re-
activity to the same extent suggested that the adhesion role of
CD8aa depended solely on the interaction of its extracellular
part with MHC class I molecules (Miceli et al., 1991). Unlike the
enhanced CD8ab TCR coreceptor function, however, cell-cellImmunity 28, February 2008 ª2008 Elsevier Inc. 151
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cated that CD8ab did not increase cell adhesion or affinity for
MHC class I ligands as compared to CD8aa (Garcia et al.,
1996; Sun and Kavathas, 1997). The comparable adhesion me-
diated by CD8aa or CD8ab is in strong contrast to the superior
ability of membrane-bound CD8ab to function as a TCR co-
receptor. Therefore, the same characteristics that underscore152 Immunity 28, February 2008 ª2008 Elsevier Inc.the importance of CD8b as the hallmark of an efficient CD8
TCR coreceptor equally support the notion that CD8aa is not
a functional homolog of CD8ab TCR coreceptor. The require-
ment for effective CD8ab coreceptor function as opposed to in-
creased adhesion is most striking in conjunction with weak anti-
gens and implies that the TCR coreceptor function is to enhance
antigen sensitivity of low-affinity TCRs (Kerry et al., 2003; MaileFigure 1. CD8aa Corepressor Function on Different Cell Types
Unlike the conventional coreceptors, CD8ab and CD4, CD8aa repressor is excluded from lipid rafts that contain the TCR-CD3 (CD3z and/or Fc3Rg+) activation
complexes engaged with antigen-presenting MHC molecules. CD8aa corepressor negatively regulates TCR activation by disrupting lipid rafts and by seques-
tering signaling molecules required for TCR-initiated downstream signaling.
(A) CD4+CD8ab+CD8aa+ TP thymocytes interact with MHC and self-antigens during agonist selection in the thymus. CD8aa repressor may sequester Lck and
LAT, allowing for transient reduction in signal strength received through the agonist-selected TCRs.
(B) Some peripheral CD8ab+ T cells transiently induce CD8aa upon primary activation with agonist ligands. CD8aa repressor on these activated T cells may tem-
porarily sequester Lck and LAT and allow for transient reduction in signal strength received through the agonist-triggered TCRs.
(C) Left: Conventional coreceptor-dependent effector T cells reinduce CD8aa under the conditions of the gut microenvironment. The constitutive presence of
CD8aa repressor may increase the threshold for activation on these antigen-experienced T cells that reside within the antigen-rich environment of the gut.
CD8aa may interact with its ligand, TL, which is abundantly expressed by the gut epithelial cells and promote long-term survival of the antigen-experienced
T cells. Right: DN TCRab+ thymocytes reinduce CD8aa upon migration to the gut. Constitutive expression of CD8aa repressor on these self-specific corecep-
tor-independent T cells might prevent aberrant self-reactivity. Interaction of CD8aa with TL ligand could promote long-term survival of these self-antigen-expe-
rienced T cells.
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coreceptor dependent for their activation and initial selection.
With this in mind, a study with retroviral transfection of CD8-de-
pendent and -independent TCRs into primary T cells isolated
from wild-type or CD8b-deficient mice demonstrated that
CD8aa cannot support activation of CD8-dependent TCRs,
thus supporting the notion that CD8aa does not function as
a TCR coreceptor (McNicol et al., 2007). In contrast, high-affinity
TCRs, which function in the absence of coreceptors and appear
on double-negative (DN) T cells, often express CD8aa (Levelt
et al., 1999; Mixter et al., 1999; Wang et al., 2002; Gangadharan
and Cheroutre, 2004). The expression of CD8aa in conjunction
with high-affinity TCRs or the induction of CD8aa with increased
TCR signal strength further cast doubts on CD8aa functions as
a coreceptor to enhance antigen sensitivity of the TCR. Instead,
the observations that enforced transgenic expression of CD8aa
on DN thymocytes greatly impaired intracellular calcium re-
sponses and blocked efficient tyrosine phosphorylation of sig-
naling components in response to TCR ligation suggest that
CD8aamight function as a negative regulator of TCRs (van Oers
et al., 1993). Consistent with this, with TCR transgenic T cell lines
that express TCRs with identically affinity, it was demonstrated
that coexpression of CD8aa together with CD8ab specifically
suppressed the CD8ab-mediated increase in Ag sensitivity
(Cawthon et al., 2001; Cawthon and Alexander-Miller, 2002).
Similar to other TCR corepressors, including CTLA-4 (Egen
and Allison, 2002), CD8aa can be induced upon activation
through the TCR-CD3 complex and the degree of induction in-
creases proportionally to the signal strength (Barnden et al.,
1997; Levelt et al., 1999; Cawthon et al., 2001; Wang et al.,
2002; Madakamutil et al., 2004). Consequently, activation-in-
duced CD8aa is directly related to the functional avidity of the
activation complex and inversely related to the CD8ab corecep-
tor dependency of the participating TCR. Because coexpression
of CD8aa effectively decreases the functional avidity of TCRs
and markedly diminishes or completely abolishes activation
(van Oers et al., 1993; Cawthon et al., 2001), it can be concluded
that CD8aa is not a redundant coreceptor but instead that
CD8aa functions more likely as an effective TCR corepressor.
Further, because CD8aa can be transiently induced on activated
CD8ab+ T cells (Madakamutil et al., 2004) or constitutively ex-
pressed on IEL (Cheroutre, 2004), its inhibitory effect could either
temporarily lower the functional avidity and attenuate an ongoing
immune response (Figure 1B) or permanently increase the mini-
mum signal strength required for restimulation of antigen-expe-
rienced T cells (Figure 1C). Although it is not fully understood how
CD8aa functions as a corepressor, its ability to interact with
MHC class I ligands as well as its capacity to associate with var-
ious signaling components of the TCR-CD3 complex indicate
that CD8aa has the potential to interfere with TCR-mediated
activation at different levels.
Unlike the activation-induced cointernalization of CD8ab to-
gether with TCR-CD3, CD8aa expression increases with activa-
tion and reflects the disconnection between CD8aa and the
TCR-CD3 activation complex consistent with its exclusion from
the lipid rafts (Arcaro et al., 2000; Cawthon and Alexander-Miller,
2002; Pang et al., 2007). The increased presence of CD8aa out-
side the lipid raft compartment coincides with decreased func-
tional avidity of the activation complex and indicates that theraft exclusion of CD8aa might be key to its suppressive effect
(Cawthon and Alexander-Miller, 2002). It is thus possible that
CD8aa binds non-lipid-raft-associated p56lck and LAT and
hence sequesters these signaling components from CD8ab
and TCR-CD3 activation complexes (Figure 1; Gangadharan
and Cheroutre, 2004). Although this is a reasonable hypothesis,
the enhanced capacity of CD8ab coreceptor to effectively asso-
ciate with p56lck and LAT (Bosselut et al., 2000) would indicate
that other mechanisms, in conjunction with the raft exclusion,
might contribute to the repressor role for CD8aa. The efficient
colocalization of CD8ab together with TCR-CD3 activation com-
plexes depends on the integrity of lipids rafts and the larger or-
ganization into membrane platforms (Horejsi, 2003). The ob-
servations that expression of CD8aa markedly reduces the
colocalization and association of CD8ab and TCR-CD3 could in-
dicate that CD8aa actively disrupts the lipid raft integrity and
thus abrogates the optimal association of CD8ab with TCR
(Cawthon and Alexander-Miller, 2002). Lipid raft disruption as
a mechanism to interfere with TCR-CD3 activation has been de-
scribed for other TCR repressors, including CTLA-4 (Rudd et al.,
2002). Similarly to the CD8aa-CD8ab coreceptor pair, CTLA-4
interacts with the same B7 ligands as its partner, CD28, but dis-
plays opposite functions: whereas CD28 serves as a TCR costi-
mulatory receptor, CTLA-4mediates TCR repressor activity (Ale-
gre et al., 2001). CTLA-4 is also induced proportionally to the
TCR signal strength (Egen and Allison, 2002), and together these
observations suggest that lipid raft disruption and interference
with colocalization of signalingmoleculesmight be a general fea-
ture of repressors that are paired with TCR coreceptors. The re-
pressor activity of CD8aa, however, is not limited to CD8ab, and
CD8aa-mediated suppression of DN thymocytes indicates that
CD8aa can also directly serve to negatively regulate TCR-CD3
complexes, independently of conventional TCR coreceptors
(Figure 1C; van Oers et al., 1993).
The CD8a cytoplasmic tail does not contain any immunore-
ceptor tyrosine-based inhibition motifs (ITIMs) typical of inhibitor
receptors. In contrast, it is possible that CD8aa actively associ-
ates with inhibitory molecules as has been described for LAG-3,
a TCR activation-induced repressor with close homology to the
TCR coreceptor CD4 (Workman and Vignali, 2005). Similar to
the CD8aa-CD8ab receptor pair, LAG-3 shares MHC class II
ligands with CD4 but serves to negatively regulate TCR-CD3
activation in part by actively recruiting intracellular inhibitory
molecules (Iouzalen et al., 2001). Although no specific inhibitory
molecules have been identified that directly bind to the cytoplas-
mic tail of CD8a, it is tempting to speculate that the linker for ac-
tivation of B cells (LAB, NTAL, and recently renamed LAT2), a ho-
molog of LAT, absent in naive T cells but transiently induced on
activated T cells (Zhu et al., 2006) and abundantly expressed by
CD8aa+ IEL (Denning et al., 2007), might serve as an inhibitory
adaptor for CD8aa. Although LAT2 also becomes phosphory-
lated in association with ITAM-containing activation receptors,
including the Fc3RIg, it can actively compete with LAT and neg-
atively regulate its activity in T cells (Zhu et al., 2006). It is inter-
esting to note that the transiently induced CD8aa and LAT2 on
activated T cells and the constitutive expression of these mole-
cules on CD8aa+ IEL also coincide with transiently or constitu-
tively expressed Fc3RIg (Figure 1C). In T cells, Fc3RIg can partic-
ipate in the CD3 complex, replacing CD3z dimers or formingImmunity 28, February 2008 ª2008 Elsevier Inc. 153
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2003). For every three ITAM motifs present in each CD3z chain,
there is only one ITAM per Fc3RIg unit, and hence it is possible
that the reduced CD3 phosphorylation targets together with
the counteracting effect of LAT2 on LAT and the presence of
CD8aa are all part of various suppressionmechanisms that func-
tion in concert to increase the threshold for productive T cell
activation. Membrane-bound CD8aa negatively regulates core-
ceptor-dependent or coreceptor-independent TCR activation
regardless of a productive interaction between its extracellular
domain and the antigen-presenting MHC class I molecules
(Cawthon et al., 2001). This is in sharp contrast to the potent ca-
pacity of soluble CD8aa (sCD8aa) molecules or CD8a-derived
peptides to block the interaction between MHC and the CD8ab
coreceptor (Choksi et al., 1998; Kern et al., 1999; Sewell et al.,
1999). The interference by sCD8aa results in the inhibition of
CD3z tyrosine phosphorylation and indicates that the blocking
by sCD8aa targets the earliest stage of activation consistent
with inhibition of p56lck activation. The inhibition by sCD8aa
does not affect high-affinity TCRs expressed on DN T cells and
implies that the suppression mechanism of sCD8aa specifically
targets low-affinity TCRs that require CD8ab coreceptor function
for their activation (Kwan-Lim et al., 1993; Sewell et al., 1999;
Kerry et al., 2003). Similar suppressive effects have also been
observed with CD8 antibodies that interrupt the interaction of
CD8abwithMHC ligand (Sewell et al., 1999). The inhibitory effect
of sCD8aa is remarkably potent and only a minority of CD8ab-
MHC class I interactions need to be obstructed by sCD8aa to
prevent T cell activation (Sewell et al., 1999). sCD8aa arises
from alternative spliced mRNA in which the exon encoding the
transmembrane domain has been deleted (Giblin et al., 1989;
Norment et al., 1989). sCD8aa occurs naturally in human and
correlates with advanced stages of various diseases including
T cell leukemia, rheumatoid arthritis, multiple sclerosis, systemic
lupus erythematosus, and HIV infection. In mouse, an alternative
spliced form of CD8a has been described as well, but in contrast
to human sCD8aa, alternatively spliced mouse CD8a mRNA
retains the transmembrane domain and results in membrane-
bound tail-less CD8a’ molecules (Zamoyska et al., 1985,
1989). Although all T cells transcribe and translate CD8a’, only
immature thymocytes express CD8a’b heterodimers at their
cell surface, whereas mature T cells retain terminally sialylated
CD8a’-containing complexes intracellularly (Zamoyska and
Parnes, 1988).Membrane-boundCD8a’ lacks the ability to asso-
ciate with p56lck, and therefore, even though it has an intact ex-
tracellular domain that can interact with MHC class I molecules,
it is unable to function as a TCR coreceptor subunit (Zamoyska
et al., 1989). It is interesting to note that an ancestral form of
CD8a expressed in lower vertebrates has also retained the pro-
totype CD8 Ig-like ectodomain as well as the hinge and trans-
membrane domain, whereas it lacks the p56lck consensus bind-
ing motif in the cytoplasmic portion, suggesting that these two
physically linked functional units might have evolved separately
(Hansen and Strassburger, 2000).
CD8aa and Thymic Differentiation
of Agonist-Selected T Cells
Because of its structural homology and shared MHC class I li-
gands, CD8aa has unjustly been labeled as an alternative TCR154 Immunity 28, February 2008 ª2008 Elsevier Inc.coreceptor for CD8ab. The observation that conventional mature
MHC class I-restricted T cells are lacking in the periphery of
CD8b-deficient mice indicated that CD8aa, abundantly ex-
pressed on Cd8b/ DP thymocytes, are incapable of providing
a coreceptor function during thymic selection (Crooks and Litt-
man, 1994; Fung-Leung et al., 1994; Nakayama et al., 1994). In
contrast, mature CD8aa+TCRab+ IEL develop normally in these
Cd8b/ mice, indicating that CD8aa+SP IEL are independent
of CD8ab coreceptor for their development (Leishman et al.,
2002). The absence of these CD8aa+TCRab+ T cells in b2 m/
mice (Sydora et al., 1996) indicates that they either express
a CD8 coreceptor-independent but MHC class I-dependent
TCR, or that an interaction between the constitutively expressed
CD8aa and MHC class I ligand maintains survival of the mature
cells, perhaps by increasing the threshold for productive activa-
tion of their TCRs. The latter would be in agreement with the find-
ing that these T cells express high-affinity TCRs that function typ-
ically in a coreceptor-independent fashion. Also consistent with
this is the observation that the TCR repertoire of these CD8aa+
TCRab+ IEL is greatly enriched for high-affinity self-reactive
TCRs that are otherwise deleted from the normal T cell repertoire
during thymic-negative selection (Rocha et al., 1991). The pres-
ence of self-reactive T cells among the CD8aa+TCRab+ IEL has
been used as evidence that these TCRab+ T cells developed ex-
trathymically (Rocha et al., 1991). Other data, however, indicate
that self-specific CD8aa+TCRab+ IEL are thymus selected (Lam-
bolez et al., 2007).We have shown that somepreselected thymo-
cytes express CD8aa at the immature DP stage (Gangadharan
et al., 2006). By using TCR transgenic cells, we demonstrated
that in contrast to DP thymocytes, these CD8aa-expressing tri-
ple-positive (TP) thymocytes survived and differentiated to DN
or CD8aa+ T cells when exposed to their cognate antigen in vitro
(Figure 2A; Gangadharan et al., 2006). Intrathymic injection of TP
thymocytes generated a substantial population of CD8aa+
TCRab+ IEL, whereas their DP counterparts generated exclu-
sively conventional coreceptor-positive T cells in the periphery.
These results provided direct evidence that TP thymocytes are
precursors of agonist-selected T cells. Although it is not under-
stood how these TP thymocytes can survive under agonist selec-
tion conditions, it is consistent with a repressor function for
CD8aa that allows for a transient reduction of signal strength re-
sulting in survival of these agonist-selected thymocytes. We
identified the TCRab+ DN thymocytes as the mature post ago-
nist-selected thymic precursors and showed that upon transfer,
these cells readily generated CD8aa+TCRab+ IEL in vivo (Gang-
adharan et al., 2006). The DN phenotype of agonist-selected IEL
precursors is consistent with the accumulation of coreceptor-
independent high-affinity TCRs among CD8aa+TCRab+ IEL.
CD8aa expression on the TP thymocytes is also activation in-
duced; however, unlike on mature T cells, CD8aa induction on
these immature cells does not depend on a full TCRab or any
MHC ligation (Gangadharan et al., 2006). Together with the ob-
servation that CD8aa is induced on anti-CD3-triggered Rag1/
DN thymocytes, this indicates that the inducing signal for CD8aa
on immature thymocytes might be given by the pre-TCR during
TCRb selection. The agonist selection pathway that allows for
selective survival of precursor cells that express TCRs with
high affinity for self also endows these cells with an activation-
induced differentiation program and further underscores the
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drive for the unique differentiation and specialization of these
self-specific mucosal memory CD8aa+ T cells.
CD8aa and Peripheral Differentiation of Memory T Cells
Conventionally selected T cells differentiate to memory T cells
in response to cognate nonself antigens encountered in theperiphery (Sprent and Surh, 2002). The generation of immune
memory provides the individual with enhanced protective immu-
nity upon secondary encounter of the antigen (Sprent and Surh,
2002). Although it is nowwell established that memory T cells are
direct descendants of primary effector T cells, it is still poorly un-
derstood why some effectors survive and differentiate to mem-
ory cells whereas the bulk of the effector population undergoesFigure 2. The Pathways of Agonist Selection in the Thymus and Effector Memory Differentiation in the Periphery Show Parallel Features
for CD8aa-Expressing Cells
(A) In the thymus, CD8aa-expressing immature TP thymocytes may survive agonist selection conditions that otherwise delete CD8aa-negative DP counterparts.
Positive-selected TP thymocytes differentiate to DN TCRab+ mature cells that gain the capacity to migrate to the intestine and adapt the CD4CD8abCD8aa+
TCRab+ IEL phenotype in the IL-15-rich environment of the gut.
(B) In the periphery, CD8aa-expressing primary effector CD8ab+TCRab+ T cells survive agonist-induced activation and differentiate to SPCD8ab+ TCRab primary
effector T cells that gain the capacity tomigrate to the intestine. Conventional CD8ab+TCRab+ effector cells reinduce CD8aa in the presence of IL-15, locally in the
gut, and reside there long-term as CD8aa+CD8ab+ TCR IEL with an effector memory phenotype.Immunity 28, February 2008 ª2008 Elsevier Inc. 155
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Reviewfull activation followed by activation-induced cell death. Interest-
ingly, this process of memory differentiation has much in com-
mon with the selective survival and specific differentiation of
CD8aa+TCRab+ IEL precursor cells during agonist selection in
the thymus (Figure 2). Consistentwith this,we showed that a sub-
set of primary effector CD8ab+ T cells transiently induce CD8aa
during early activation, and upon transfer, they showed in-
creased capacity to survive and differentiate to memory T cells
(Madakamutil et al., 2004). The transient induction of CD8aa
on some of the responding CD8ab+ T cells is controlled by the
enhancer E8I, and E8I-deficient CD8ab
+ T cells are unable to
induce CD8aa expression in response to anti-CD3 stimulation
in vitro (Madakamutil et al., 2004). Consistent with an important
role for CD8aa during CD8ab+ memory T cell differentiation,
we showed that E8I-deficient mice were greatly impaired in the
generation of memory CD8ab T cells (Madakamutil et al.,
2004). The indication that membrane-bound CD8aa can be sup-
pressive regardless of MHC ligation and the observation that
memory T cells can be generated in the absence of TL expres-
sion (Williams and Bevan, 2005) would suggest that the critical
role for CD8aa during memory differentiation is TL independent
and that specific ligation of the CD8aa extracellular domain with
TL or any other MHC class I molecule expressed by the APC is
not required for survival and differentiation of memory precursor
cells. It is thus possible that activation-induced CD8aa tran-
siently abrogates ongoing activation by negatively intercepting
TCR-CD3 complex-mediated signals via its cytoplasmic do-
main, alone (Figures 1B and 2B).
Not all memory precursors require CD8aa for their initial sur-
vival and differentiation, and other mechanism can lead to
CD8ab+ memory T cells via CD8aa-independent mechanisms
(Chandele and Kaech, 2005; Zhong and Reinherz, 2005). It is
not known, however, whether the CD8aa-dependent memory
cells differ in their phenotype, functional, and/or specific homing
abilities from those generated via CD8aa-independent pro-
cesses. Nevertheless, the induction of CD8aa at the initiation
of an immune response, when the antigen dose is high, and
the proportional relationship between the degree of CD8aa in-
duction and TCR signal strength would imply that the CD8aa-de-
pendent pathway of memory differentiation is an early activation
event and selectively preserves effector T cells with high affinity
or avidity for non-self antigens. Together with the observation
that memory precursor cells that emerge under strong activation
conditions preferentially differentiate to effector memory T (TEM)
cells, this would indicate that CD8aa-dependent memory differ-
entiation selectively preserves the ‘‘fittest’’ effector cells to differ-
entiate to TEM cells that can provide protective immunity at
peripheral sites that have the highest and most likely probability
for re-entry of the pathogens.
CD8aa and Mucosal T Cells
Agonist-selected self-specific DN thymocytes or effector mem-
ory CD8ab T cells that migrate to the intestine reinduce and
maintain CD8aa expression, suggesting that continuous sup-
pression by CD8aa on these antigen-experienced T cells might
be part of the mucosal immune regulation to mediate immune
quiescence in the antigen-rich environment of the gut. In addi-
tion, it is also possible that the interaction of CD8aa on the IEL
with its ligand TL constitutively expressed by the intestinal156 Immunity 28, February 2008 ª2008 Elsevier Inc.epithelium (Hershberg et al., 1990) might regulate their homeo-
static proliferation (Yamamoto et al., 1998) and promote long-
term survival of these cells in the absence of IL-7R signals
(Figure 1C; Masopust et al., 2006). Interaction with TL ligand
can also stabilize prolonged expression of CD8aa and modify
activation signals (Leishman et al., 2002; Madakamutil et al.,
2004). The constitutive presence of CD8aa on these cells prob-
ably does not present an indefinite shut off of the activation po-
tential, and it has been shown that increased antigen stimulation
or crossligation of CD8 and TCR can override negative regulation
by CD8aa (Sewell et al., 1999; Cawthon et al., 2001). The consti-
tutive re-expression of CD8aa on agonist-selected self-specific
DN IEL as well as on effector memory CD8ab T cells indicates
that CD8aa repressor induction is a general feature for mucosal
T cells and serves as an active suppression mechanism to keep
high-affinity and previously activated T cells in check by lowering
their sensitivity for self or non-self antigens, but ready to go
whenever the specific antigen load surpasses the increased
threshold.
CD8aa on Non-T Cells
The expression and function of CD8aa is not exclusively in con-
junction with TCR-CD3, and CD8aa can also be expressed on
non-T cells, including NK cells and subsets of DCs, mast cells,
and macrophages. Furthermore, human NK cells that express
CD8aa are more cytotoxic than their CD8aa-negative counter-
parts (Srour et al., 1990). This is due to an indirect effect of
CD8aa ligation on the NK cell that protects the NK effector cells
from induced apoptosis. As a result, CD8aa+ NK cells are capa-
ble of sequential lysis of multiple target cells (Addison et al.,
2005). This ligation is through interaction with fellow NK cells
and is independent of ligands expressed on the target cells. Pro-
tection from apoptosis is blocked by preincubation of the NK
cells with MHC class I antibodies, suggesting that an interaction
between CD8aa and MHC class I molecules expressed by the
NK cells has antiapoptotic effects. It is not known how CD8aa
mediates its effects on non-T cells, but it is tempting to speculate
that the ability of CD8aa to modify activation signaling mediated
by the invariant CD3 complex might extend its function to also
control invariant ITAM-containing activation receptors such
as FcRs expressed by these innate cells. The expression of
CD8aa on different innate cell lineages indicates that in contrast
to the MHC class I-restricted coreceptor function for CD8ab on
T cells, CD8aa might serve as a universal positive or negative
modulator for a broad range of activating receptors that span
adaptive and innate immune responses.
Conclusions
Looks are deceiving and much has been assumed about CD8aa
because of its striking structural homology with the CD8ab cor-
eceptor. This misconception not only has led to incorrect inter-
pretations for the function of CD8aa but it has also generated
profound confusion and misunderstanding regarding the ontog-
eny and function of CD8aa-expressing T cells. The presence of
CD8aa has been used as a marker for unconventional IEL and
their thymic predecessors and for conventional CD8ab+ mem-
ory precursor cells. When assuming a redundant, ineffective
coreceptor function for this molecule, the expression of
CD8aa on T cells represents merely a marker of no functional
Immunity
Reviewimportance. However, when CD8aa is considered a potent co-
repressor induced on immature thymocytes or primary effector
cells or re-expressed on mature antigen-experienced cells in
the intestine, the importance of CD8aa as a key regulator of ac-
tivation and differentiation becomes unquestionable. It is there-
fore of utmost importance to consider the repressor function of
CD8aa for future analysis of this molecule and for reinterpreta-
tion of existing data considering the role of CD8aa during T cell
differentiation processes as well as the controversial data that
surrounds the ontogeny and function of CD8aa-expressing
T cells.
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